Corporation is extending its groundbreaking MindBody GLP-1 System to international markets. This expansion comes after a 49% ...
Lake Street analyst Brooks O’Neil maintained a Buy rating on LifeVantage (LFVN – Research Report) today and set a price target of $30.00. The ...
LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is proud to announce the addition ...
LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its ...